Prof Giagounidis discusses the effects of one TPO-R agonist after discontinuing another at the idiopathic thrombocytopenic purpura symposium at EHA 2014.
GlaxoSmithKline fully provided for the costs of this symposium, honoraria for the Chairs & speakers and provided input into the symposium agenda/content.